Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
Agarwal, N., Brugarolas, J., Ghatalia, P., George, S., Haanen, J.B., Gurney, H., Ravilla, R., Van der Veldt, A., Beuselinck, B., Pokataev, I., Suelmann, B.B.M., Tuthill, M.H., Vaena, D., Zagouri, F., Wu, J., Perini, R.F., Liu, Y., Merchan, J., Atkins, M.B.
Published in Annals of oncology (02.09.2024)
Published in Annals of oncology (02.09.2024)
Get full text
Journal Article
Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report
ElNaggar, A., Zhang, N., Scalise, C.B., Sirard, C., Kagey, M.H., Vaena, D., Arend, R.
Published in Gynecologic oncology reports (01.02.2022)
Published in Gynecologic oncology reports (01.02.2022)
Get full text
Journal Article
Efficacy of cabozantinib vs everolimus in advanced renal cell carcinoma with bone metastases: results from the phase 3 METEOR study
Bracarda, S, Choueiri, T.K, Powles, T, Motzer, R.J, Olencki, T, Frontera, O.A, Oudard, S, Rolland, F, Tomczak, P, Castellano, D, Appleman, L, Drabkin, H, Vaena, D, Milwee, S, Youkstetter, J, Escudier, B
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
1881O Safety and efficacy of two doses of belzutifan in patients (pts) with advanced RCC: Results of the randomized phase II LITESPARK-013 study
Agarwal, N., Brugarolas, J., Ghatalia, P., George, S., Haanen, J.B.A.G., Gurney, H.P., Ravilla, R., Van der Veldt, A.A.M., Beuselinck, B., Pokataev, I., Suelmann, B.B., Tuthill, M., Vaena, D., Zagouri, F., Wu, J., Liu, Y., Perini, R., Merchan, J.R., Atkins, M.B.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Long-Term Survival After High-Dose Salvage Chemotherapy for Germ Cell Malignancies With Adverse Prognostic Variables
VAENA, Daniel A, ABONOUR, Rafat, EINHORN, Lawrence H
Published in Journal of clinical oncology (15.11.2003)
Published in Journal of clinical oncology (15.11.2003)
Get full text
Journal Article
Conference Proceeding
917P - Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Siefker-Radtke, A.O., Lugowska, I., Tupikowski, K., Andric, Z.G., Rezazadeh Kalebasty, A., Curigliano, G., Vaena, D., Vogl, F.D., Currie, G., Abella, S., Kelly, W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
917PClinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Siefker-Radtke, A O, Lugowska, I, Tupikowski, K, Andric, Z G, Rezazadeh Kalebasty, A, Curigliano, G, Vaena, D, Vogl, F D, Currie, G, Abella, S, Kelly, W
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Siefker-Radtke, A.O., Lugowska, I., Tupikowski, K., Andric, Z.G., Rezazadeh Kalebasty, A., Curigliano, G., Vaena, D., Vogl, F.D., Currie, G., Abella, S., Kelly, W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Efficacy and safety of nivolumab monotherapy in patients with metastatic urothelial cancer (mUC) who have received prior treatment: Results from the phase II CheckMate 275 study
Galsky, M.D., Retz, M., Siefker-Radtke, A.O., Baron, A., Necchi, A., Bedke, J., Plimack, E.R., Vaena, D., Grimm, M.-O., Bracarda, S., Arija, J. Arranz, Pal, S.K., Ohyama, C., Saci, A., Lambert, A., Krishnan, S., Azrilevich, A., Sharma, P.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
390 COM701 (a novel immune checkpoint inhibitor) in patients with advanced solid tumors
Elnaggar, A, Luke, J, Hamilton, E, Chmielowski, B, Ileana-Dumbrava, E, Patnaik, A, Lim, E, Adewoye, A, Hunter, J, Olweny, J, Sharma, M, Sullivan, R, Vaena, D, Rasco, D
Published in International journal of gynecological cancer (01.09.2019)
Published in International journal of gynecological cancer (01.09.2019)
Get full text
Journal Article
130P COM701 ± nivolumab: Preliminary results of antitumor activity from a phase I study in patients with metastatic NSCLC who have received prior PD-1/PD-L1 inhibitor
Sullivan, R.J., Sharma, M.R., Vaena, D., Hamilton, E., Izar, B., Rasco, D., Gainor, J., D. Shepard, Papadopoulos, K., Dumbrava, E.E., Adewoye, H.H., Ferre, P.J., Ophir, E., Patel, M., Patnaik, A., Chmielowski, B.
Published in Immuno-oncology technology (01.12.2022)
Published in Immuno-oncology technology (01.12.2022)
Get full text
Journal Article
159P COM701 in combination with nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant epithelial ovarian cancer
Yeku, O., D. Shepard, Patel, M., Fleming, G., Vaena, D., Rasco, D., Chmielowski, B., Sharma, M.R., Hamilton, E., Sullivan, R.J., Papadopoulos, K., Izar, B., Cojocaru, G., Ophir, E., Ferre, P.J., Dumbrava, E.E.
Published in Immuno-oncology technology (01.12.2022)
Published in Immuno-oncology technology (01.12.2022)
Get full text
Journal Article
158P Triple blockade of the DNAM-axis with COM701 + BMS-986207 + nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant OVCA
Moroney, J., Yeku, O., Fleming, G., Emens, L.A., Vaena, D., Dumbrava, E.E., Rasco, D., Sharma, M.R., Papadopoulos, K., Patnaik, A., Sullivan, R.J., Adewoye, H.H., Ophir, E., Cojocaru, G., Ferre, P.J., Izar, B., Gaillard, S.
Published in Immuno-oncology technology (01.12.2022)
Published in Immuno-oncology technology (01.12.2022)
Get full text
Journal Article
2196 - Efficacy of cabozantinib vs everolimus in advanced renal cell carcinoma with bone metastases: results from the phase 3 METEOR study
Bracarda, S., Choueiri, T.K., Powles, T., Motzer, R.J., Olencki, T., Frontera, O.A., Oudard, S., Rolland, F., Tomczak, P., Castellano, D., Appleman, L., Drabkin, H., Vaena, D., Milwee, S., Youkstetter, J., Escudier, B.
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
A25 LUNG INJURY: MARKERS AND OUTCOMES: Sonographic B-Lines Correlate With Plasma Angiopoietin-2 During Early Acute Lung Injury Induced By Clinical Interleukin-2 Therapy
Gores, K, Delsing, A, Monick, M M, Gehlbach, B K, Schmidt, G A, Durairaj, L, Vaena, D, Milhem, M, Gerke, A K, Zabner, J, Doerschug, K
Published in American journal of respiratory and critical care medicine (01.01.2014)
Get full text
Published in American journal of respiratory and critical care medicine (01.01.2014)
Journal Article
Genetic variability in DNA repair and clinical outcome in stage III non-small cell lung cancer (NSCLC) treated with concurrent platinum-based chemoradiation
Al Omari, A., Murry, D. J., Smith, B. J., Clamon, G., Bhatia, S., Vaena, D.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Radiolabeled anti-prostate specific membrane antigen (PSMA) monoclonal antibody J591 ( 177 Lu-J591) for nonmetastatic castration-resistant prostate cancer (CRPC): A randomized phase II trial
Tagawa, S. T., Hahn, N. M., Vaena, D. A., Quinn, D. I., Kelly, W. K., Christos, P. J., Osborne, J., Vallabhajosula, S., Nadeau, K., Mileo, G., Tyrell, L., Saran, A., Ecker, C., Beltran, H., Goldsmith, S. J., Nanus, D. M.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Bevacizumab plus interferon-alpha versus interferon-alpha monotherapy in patients with metastatic renal cell carcinoma: Results of overall survival for CALGB 90206
Rini, B. I., Halabi, S., Rosenberg, J., Stadler, W. M., Vaena, D. A., Atkins, J. N., Picus, J., Czaykowski, P., Dutcher, J., Small, E. J.
Published in Journal of clinical oncology (20.06.2009)
Published in Journal of clinical oncology (20.06.2009)
Get full text
Journal Article